Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " April 30, 2008":" May 30, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated
Has Results
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Conditions: Non-alcoholic Steatohepatitis;   Chronic Liver Disease;   HCV;   NASH.;   HIV Infection;   Thrombocytopenia;   Hepatitis C Virus;   HBV;   Human Immunodeficiency Virus;   Liver Diseases;   Hepatitis B Virus
Interventions: Drug: Eltrombopag;   Drug: Placebo
22 Terminated Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
Conditions: Atherosclerosis;   HIV Infections
Interventions: Drug: Rosuvastatin;   Drug: Placebo
23 Completed Age-17 Follow-up of Home Visiting Intervention
Conditions: Antisocial Behavior;   Psychopathology;   Substance Use;   HIV Infections
Intervention: Behavioral: Nurse Home Visitation
24 Completed Neurocognitive Assessment in Youth Initiating HAART
Condition: HIV Infections
Interventions: Drug: Early Treatment with HAART;   Other: No treatment;   Drug: HAART Treatment - standard care
25 Completed Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Condition: HIV Infections
Interventions: Other: Standard (static) Computer Alerts;   Other: Enhanced Computer Alerts
26 Completed
Has Results
Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences
Condition: HIV Infections
Intervention:
27 Completed Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections
Interventions: Drug: GPO-Vir Z30 tablet;   Drug: Lamivudine;   Drug: Nevirapine;   Drug: Zidovudine
28 Completed TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
29 Terminated Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children
Condition: Hypertriglyceridemia
Interventions: Drug: Omega Pure followed by placebo;   Drug: Placebo followed by Omega Pure
30 Terminated
Has Results
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Kaposi's Sarcoma
Interventions: Drug: VEGF inhibitor PTC299;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years